# FDA Inspection 1235669 - Jiangsu Puxin Pharmaceuticals Development Co. Ltd - March 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-puxin-pharmaceuticals-development-co-ltd/5221e2aa-e069-4027-8fb4-149ec5d07571
Source feed: FDA_Inspections

> FDA Inspection 1235669 for Jiangsu Puxin Pharmaceuticals Development Co. Ltd on March 15, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235669
- Company Name: Jiangsu Puxin Pharmaceuticals Development Co. Ltd
- Inspection Date: 2024-03-15
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 875388 - 2014-03-28](https://www.keypedia.com/records/fda_inspections/jiangsu-puxin-pharmaceuticals-development-co-ltd/9bc5d1ed-bb2e-464e-8f88-eec3a2468660)
- [FDA Inspection 790436 - 2012-05-31](https://www.keypedia.com/records/fda_inspections/jiangsu-puxin-pharmaceuticals-development-co-ltd/89cca04c-76fd-4ef2-9494-73c99a9a8042)

Company: https://www.keypedia.com/companies/jiangsu-puxin-pharmaceuticals-development-co-ltd/58d3558c-02ba-4f60-8963-48ba3bf709bd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c